Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Neonates with Hypoxic Ischemic Encephalopathy
IRCT20230605058385N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in hypoxic-ischemic encephalopathy (HIE), sponsored by Mashhad University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
melatonin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on IRCT20230605058385N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230605058385N1.